FDA, EMA propose more efficient approach to drug development
The US Food and Drug Administration (FDA) has released a new draft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases.
Archives for December 6, 2017
EHR to EDC: New software solution ‘ingests’ output data as solution to interoperability
Crucial Data Solutions, Inc. and its strategic partner Zircon Technologies have teamed up to release a “first-of-its-kind” software solution developed to accelerate the clinical trials process.
News in Brief
PsychoGenics, Blue Oak partner to identify new treatments for brain disorders
Blue Oak Pharmaceuticals, Inc. and PGI Drug Discovery LLC (PsychoGenics) have entered into a drug discovery partnership to optimize novel treatments for brain disorders and psychiatric conditions.
ERT pumps up cardiac safety solutions with iCardiac acquisition
ERT’s purchase of iCardiac Technologies follows three months after its purchase Biomedical Systems, the additions of which further increase the company’s portfolio of cardiac safety solutions.
Russian demand for pharma products outweighs isolationist policy
Slovakian contract manufacturer Saneca says the opportunity to tap the Russian market is huge despite protectionist policies and changing GMP inspection requirements.
GSK and Novartis sued following claims Voltaren packaging ‘misleads’ consumers
Australia’s consumer commission has accused GlaxoSmithKline and Novartis of marketing and pricing two of its Voltaren pain relief products – which contain the same active ingredient – differently.
Seaweed extracts could inhibit cancer cell growth, says Australian biotech
Seaweed extracts can reduce tumour growth and improve the effectiveness of chemotherapy says Marinova, which is developing the compounds for pharmaceutical applications.